586 Monitoring the impact of MDSC targeting drugs in combination with nivolumab on activation and proliferation of tumor resident effector immune cells in patient-derived 3D-EXplore platform

• Jared Ehrhart,
• Soner Altiok,
• Brittany Bunch,
• Kelly Sussman,
• Kelly Guzman

Affiliations

Jared Ehrhart

Nilogen Oncosystems, Tampa, Florida, USA

Soner Altiok

Nilogen Oncosystems, Tampa, Florida, USA

Brittany Bunch

Nilogen Oncosystems, Tampa, FL, USA

Kelly Sussman

Nilogen Oncosystems, Tampa, FL, USA

Kelly Guzman

Nilogen Oncosystems, Tampa, FL, USA